Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Modelling to Inform HIV Programmes in Sub-Saharan Africa (MIHPSA)

Domaine:

healthcare
Créateur:
And
Éditeur:
fig
Hôte:avatar
The MIHPSA collaboration aimed to pool insights from multiple models with close engagement from stakeholders in order to inform the future design of country HIV programmes in African countries, with Malawi, Zimbabwe and South Africa.

Visit

doi.org

Tags

Epidemiological modelling

Licenses

Creative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcode

Similaires

Stakeholder engagement and mathematical modelling to inform chikungunya vaccination programmes in endemic and epidemic settingsComprehensive HIV/AIDS knowledge and HIV testing among men in sub-Saharan Africa: a multilevel modellingUpdated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.HIV/AIDS Prevalence in Sub-Saharan AfricaCorrecting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan AfricaAffordability of comprehensive community health worker programmes in rural sub-Saharan Africa

Stakeholder engagement and mathematical modelling to inform chikungunya vaccination programmes in endemic and epidemic settings

Introduction: S Despite vaccine availability and potential expansion to younger age groups, evidence

Comprehensive HIV/AIDS knowledge and HIV testing among men in sub-Saharan Africa: a multilevel modelling

Abstract This study investigated the association between comprehensive HIV/AIDS knowledge and HIV t

Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.

BACKGROUND: The integrase inhibitor dolutegravir is being considered in several countries in sub-Sah

HIV/AIDS Prevalence in Sub-Saharan Africa

Public health planning, disease burden analysis, policy evaluation, academic research Notes / chall

Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa

Background

The World Health Organization estimates that in sub-Saharan Africa about

Affordability of comprehensive community health worker programmes in rural sub-Saharan Africa

Introduction Community health worker (CHW) programmes have low costs per person